WILLIAM THOMPSON: Open Payments
NPI 1598259319 · MONROE CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 97 payments from 24 companies in 2025. Trend: 2023 $1,819 · 2024 $1,577 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $286 |
| PFIZER INC. | 10 | $259 |
| Novo Nordisk Inc | 16 | $254 |
| Merck Sharp & Dohme LLC | 7 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $99 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Viatris Specialty LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
Products named: PREVNAR 20, VERQUVO, UBRELVY, Ozempic, QULIPTA, Kerendia, Auvelity, REXULTI.
Industry payments across IN — which companies pay providers there.
